Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Infertility in Males01:23

Infertility in Males

230
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
230
Infertility in Females01:28

Infertility in Females

257
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
257
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same author

Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy.

Obstetrical & gynecological survey·2026
Same author

A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers.

Journal of translational medicine·2024
Same author

Endometrial cancer of both uterine horns in a premenopausal patient with uterine didelphys: Surgical approach and considerations for adjuvant treatment.

Gynecologic oncology reports·2024
Same author

Endometrial cancer recurrence after the use of a uterine manipulator during laparoscopic surgery.

Gynecologic oncology reports·2024
Same author

Cervical cancer screening: missed opportunities in a one-track model.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2023

Related Experiment Video

Updated: May 27, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

5.9K

Fertility Sparing Medical Management Options in Gynecologic Cancers.

Ana Kouri1, Janelle P Darby2

  • 1Department of Obstetrics and Gynecology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA. akouri@wakehealth.edu.

Current Treatment Options in Oncology
|February 19, 2025
PubMed
Summary
This summary is machine-generated.

Medical management for gynecologic cancers is increasing, offering fertility-sparing options for early-stage disease. Careful patient selection and fertility specialist involvement are crucial for successful outcomes in women desiring pregnancy.

Keywords:
Early-stageFertility sparingGynecologic cancerMedical managementNeoadjuvant treatmentReproductive age

More Related Videos

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

4.5K
Author Spotlight: Advancing Fertility Assessment with Z-Score-Based Follicle Density Evaluation in Cryopreserved Ovarian Tissue
05:42

Author Spotlight: Advancing Fertility Assessment with Z-Score-Based Follicle Density Evaluation in Cryopreserved Ovarian Tissue

Published on: October 25, 2024

1.0K

Related Experiment Videos

Last Updated: May 27, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

5.9K
Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

4.5K
Author Spotlight: Advancing Fertility Assessment with Z-Score-Based Follicle Density Evaluation in Cryopreserved Ovarian Tissue
05:42

Author Spotlight: Advancing Fertility Assessment with Z-Score-Based Follicle Density Evaluation in Cryopreserved Ovarian Tissue

Published on: October 25, 2024

1.0K

Area of Science:

  • Gynecologic Oncology
  • Reproductive Medicine
  • Medical Therapeutics

Background:

  • Increasing use of neoadjuvant therapies and assisted reproductive technology in gynecologic cancers.
  • Limited long-term data on chemotherapy's gonadotoxicity and pregnancy outcomes.
  • Emerging role of immunotherapy and targeted therapies in gynecologic malignancies.

Purpose of the Study:

  • To review current trends in medical management for gynecologic cancers.
  • To evaluate fertility-sparing treatment options and their implications.
  • To highlight the importance of patient selection and counseling for fertility preservation.

Main Methods:

  • Review of current literature on medical management and fertility-sparing treatments in gynecologic cancers.
  • Analysis of emerging therapies like immunotherapy and targeted agents.
  • Discussion of conservative management strategies for early-stage endometrial and cervical cancers.

Main Results:

  • Medical management, including neoadjuvant chemotherapy and fertility-sparing surgery, shows promise for early-stage, low-risk gynecologic cancers.
  • Conservative management is reasonable for early-stage, low-risk endometrial cancers with fertility specialist involvement.
  • Advanced stage disease or aggressive histology generally contraindicates prioritization of fertility-sparing options.

Conclusions:

  • Fertility-sparing treatments are becoming more viable for select gynecologic cancer patients.
  • Careful patient selection, counseling, and multidisciplinary care are essential.
  • Further research is needed to optimize medical management and identify appropriate candidates for fertility preservation.